Sofinnova Investments’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-47,850
Closed -$359K 86
2024
Q2
$359K Buy
47,850
+37,850
+379% +$284K 0.02% 71
2024
Q1
$248K Buy
+10,000
New +$248K 0.01% 66